Last reviewed · How we verify

NCT05963438

Comparison Of En-Masse Retraction With Two-Step Retraction Using Mini-Implant As Anchorage

Completed NA Last updated 5 September 2025
What this trial tests

NA trial testing anterior retraction in En-masse Retraction to Two- Steps Retraction in 80 participants. Completed in 4 June 2024.

Timeline
10 October 2022
Primary endpoint
4 June 2024
4 June 2024

Quick facts

Lead sponsorDow University of Health Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date10 October 2022
Primary completion4 June 2024
Estimated completion4 June 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Dow University of Health Sciences

Who can join

Adults 18 to 25, any sex, with En-masse Retraction to Two- Steps Retraction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This Randomized Control Trial will be conducted to compare the effects of en-masse retraction to two- steps retraction on sagittal, vertical and dental dimensions using mini-implant as anchorage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Dow University of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05963438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing